Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,405 | -64,767 | -52,042 | -32,702 | -16,711 |
| Depreciation Amortization | 330 | 1,554 | 1,200 | 862 | 362 |
| Accounts payable and accrued liabilities | 716 | -556 | 191 | -677 | 389 |
| Other Working Capital | -2,267 | 4,204 | 1,524 | -3,836 | -4,175 |
| Other Operating Activity | 2,779 | 11,609 | 9,615 | 4,288 | 1,206 |
| Operating Cash Flow | $-13,847 | $-47,956 | $-39,512 | $-32,065 | $-18,929 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39,046 | 54,980 | 41,288 | 26,299 | 25,251 |
| PPE Investments | 585 | -34 | -20 | N/A | N/A |
| Investing Cash Flow | $39,631 | $54,946 | $41,268 | $26,299 | $25,251 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 8,874 | 8,827 | 8,827 | 8,742 |
| Financing Cash Flow | $N/A | $8,874 | $8,827 | $8,827 | $8,742 |
| Beginning Cash Position | 37,573 | 21,709 | 21,709 | 21,709 | 21,709 |
| End Cash Position | 63,357 | 37,573 | 32,292 | 24,770 | 36,773 |
| Net Cash Flow | $25,784 | $15,864 | $10,583 | $3,061 | $15,064 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,847 | -47,956 | -39,512 | -32,065 | -18,929 |
| Capital Expenditure | N/A | -34 | N/A | N/A | N/A |
| Free Cash Flow | -13,847 | -47,990 | -39,512 | -32,065 | -18,929 |